Ignite Creation Date:
2024-05-06 @ 2:36 PM
Last Modification Date:
2024-10-26 @ 1:33 PM
Study NCT ID:
NCT04364230
Status:
COMPLETED
Last Update Posted:
2023-10-11
First Post:
2020-04-21
Brief Title:
Melanoma Vaccine Against Neoantigen and Shared Antigens by CD40 Activation and TLR Agonists In Patients With Melanoma Including Ocular Melanoma
Sponsor:
Craig L Slingluff Jr
Organization:
University of Virginia
Organization Data
Organization:
University of Virginia
Class:
OTHER
Study ID:
HSR200006
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Craig L Slingluff Jr
Lead Sponsor Class:
OTHER
Responsible Party:
Craig L Slingluff Jr
Responsible Party Title:
Professor of Surgery Director Human Immune Therapy Center
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
University of Virginia
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Celldex Therapeutics | INDUSTRY |